Press Releases September 2, 2026 04:01 PM

Oxford Lane Capital Corp. Announces Partial Redemption of 5.00% Notes Due 2027

Oxford Lane Capital Corp. announces partial redemption of $30 million 5.00% Notes due 2027

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
OXLCZ

Oxford Lane Capital Corp., a closed-end management investment company focusing on CLO debt and equity tranches, announced it will redeem $30 million aggregate principal amount of its 5.00% Notes due 2027 at $25 per Note plus accrued interest, with redemption effective October 2, 2026. The Notes trade on Nasdaq under ticker OXLCZ.

Oxford Lane Capital Corp. Announces Partial Redemption of 5.00% Notes Due 2027
OXLCZ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Oxford Lane Capital Corp. is partially redeeming $30 million of its 5.00% Notes due 2027.
  • Redemption price set at $25 per Note plus accrued interest, with redemption scheduled for October 2, 2026.
  • The company invests primarily in debt and equity tranches of CLO vehicles, impacting the investment management and financial services sector.

GREENWICH, Conn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC, OXLCL, OXLCO, OXLCZ, OXLCN, OXLCI, OXLCG and OXLCM) (the “Company,” “we,” “us” or “our”) announced today that it has called for the redemption of a portion ($30,000,000 in aggregate principal amount) of the Company’s 5.00% Notes due 2027 (the “Notes”), which are traded on the Nasdaq Global Select Market under the ticker OXLCZ. The Company will redeem $30,000,000 in aggregate principal amount of the outstanding Notes on October 2, 2026 (the “Redemption Date”). The Notes will be redeemed at a redemption price of $25 per Note, plus accrued and unpaid interest thereon from September 30, 2026 to, but not including the Redemption Date (the “Redemption Payment”).

The Notes are held in book-entry form through The Depository Trust Company (“DTC”) and will be redeemed in accordance with the procedures of DTC. Holders of the Notes will not be entitled to receive interest on those Notes on or after the Redemption Date. Following redemption, the sole remaining right of holders of the Notes shall be to receive payment of the Redemption Payment upon presentation and surrender of such Notes to the Trustee in its capacity as paying agent.

About Oxford Lane Capital Corp.

Oxford Lane Capital Corp. is a publicly-traded registered closed-end management investment company principally investing in debt and equity tranches of CLO vehicles. CLO investments may also include warehouse facilities, which are financing structures intended to aggregate loans that may be used to form the basis of a CLO vehicle.

Forward-Looking Statements

This press release contains forward-looking statements subject to the inherent uncertainties in predicting future results and conditions. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “anticipates,” “expects,” “estimates” and similar expressions) should also be considered to be forward-looking statements. These statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Certain factors could cause actual results and conditions to differ materially from those projected in these forward-looking statements. These factors are identified from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to update such statements to reflect subsequent events, except as may be required by law.

Contact:
Bruce Rubin
203-983-5280

Source: Oxford Lane Capital Corp.


Risks

  • Future results and financial conditions are uncertain and may differ materially, as disclosed in forward-looking statements.
  • Redemption of notes might impact the company’s liquidity or capital structure.
  • Dependence on CLO markets presents risks related to credit markets and structured finance conditions.

More from Press Releases

Zhihu Inc. Announces Proposed Subscription in AI-Focused Investment Fund Sep 6, 2026 Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026 Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025 Sep 4, 2026